chevron_leftBack
As of 24 April 2025, Yili Chuanning Biotechnology Co.,Ltd. has a market cap of $3.75B USD, ranking #3510 globally and #594 in China. It ranks #297 in the Healthcare sector, and #65 in the Biotechnology industry.
Key Stats
Market Cap
$3.75BUSD
27.35B CNY
Enterprise Value
$3.93BUSD
28.63B CNY
Revenue (TTM)
$790.22MUSD
5.76B CNY
EBITDA (TTM)
$315.28MUSD
2.3B CNY
Net Income (TTM)
$192.17MUSD
1.4B CNY
EBITDA Margin
40%
Profit Margin
24%
PE Ratio
19.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Xuheng Deng
open_in_new
Employees
2,881
Founded
2010
Website
klcnsw.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 5% | -6.9% | -3.1% | -13% | 25% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301301
伊犁川宁生物技术股份有限公司 Ordinary Shares Class A
ISIN: CNE100005WX0
Shares Out.:
Shares Outstanding:
615.892M1
Shares Float:
230.284M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
12.29 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Yili Chuanning Biotechnology Co.,Ltd.
Yili Chuanning Biotechnology Co.,Ltd. engages in the research and development, and industrialization of biological fermentation technology in China. It offers antibiotic intermediates, such as erythromycin thiocyanate, penicillin G potassium salt, 6-aminopenicillanic acid, 7-aminocephalosporanic acid, 7-aminodesacetoxycephalosporanic acid, desacetyl-7-aminocephalosporanic acid, and ursodeoxycholic acid. Yili Chuanning Biotechnology Co.,Ltd. was incorporated in 2010 and is based in Yining, China.
